Amgen

Earnings Preview: Amgen looks to repeat strong Neupogen sales in Q4
The Fly on the Wall
Tue, 01/28/14 - 03:57 pm
Amgen
earnings
Q4 Biotech Earnings Preview
TheStreet.com
Mon, 01/27/14 - 11:53 am
earnings
Amgen
Biogen Idec
Vertex Pharmaceuticals
Celgene
Alexion
Amgen Inc’s Next Blockbuster Drug Delivers
Motley Fool
Sat, 01/25/14 - 10:54 am
Amgen
AMG 145
hypercholesterolemia
cholesterol
Amgen cholesterol drug meets goal of third late stage trial
Yahoo/Reuters
Thu, 01/23/14 - 05:53 pm
Amgen
evolocumab
PCSK9 inhibitors
What You Need to Know About Amgen's Oncology Line-Up
Motley Fool
Thu, 01/23/14 - 09:52 am
Amgen
oncology
T-Vec
Kyprolis
Forecasting Earnings Growth And Profitability In The Biopharmaceutical Industry
Seeking Alpha
Tue, 01/21/14 - 08:14 am
earnings
United Therapeutics
Celgene
Regeneron
Biogen Idec
Acorda Therapeutics
Amgen
Gilead Sciences
Amgen partners to develop new drugs for inflammatory bowel disease
The Fly on the Wall
Wed, 01/15/14 - 09:45 am
Amgen
inflammatory bowel disease
Biologic Makers Thwart Generics: Winning Stocks
Seeking Alpha
Sat, 01/11/14 - 08:00 am
generics
biologics
Actavis
Mylan
Amgen
Novartis
Pfizer
Teva
Amgen spinoff Atara cranks its Series B up to $52M
Fierce Biotech
Fri, 01/10/14 - 06:58 pm
Amgen
Atara
Series B
oncology
kidney disease
Don't Underestimate Amgen: Part 1
Seeking Alpha
Fri, 01/10/14 - 08:37 am
Amgen
Celgene
Gilead Sciences
Biogen Idec
Amgen Vs. Merck, Lilly In Osteoporosis Competition
Seeking Alpha
Thu, 01/9/14 - 08:33 am
Amgen
Merck
Eli Lilly
osteoporosis
romosozumab
UCB Pharmaceuticals
Prolia
Forteo
Fosamax
Semantics 101: Goldman’s Biotech Downgrade and the New Biotech Consensus
Barron's
Mon, 01/6/14 - 11:44 am
biotech
Amgen
Regeneron
The Surprising Way Big Pharma Is Researching New Drugs
Motley Fool
Mon, 01/6/14 - 09:58 am
Amgen
R&D
22 Biotech Stock Predictions for 2014
TheStreet.com
Mon, 01/6/14 - 09:47 am
biotech
Vertex Pharmaceuticals
Orexigen
Retrophin
Valeant Pharmaceuticals
Questcor
Biomarin
Merck
NeoStem
Amgen
Gilead Sciences
Vanda
Keryx
Peregrine Pharmaceuticals
CelSci
Regeneron
Cempra
Dendreon
Clovis Oncology
Halozyme
NPS Pharmaceuticals
Amgen, UCB Drug Increases Bone Density in Phase 2 Trial
Drug Discovery and Development
Fri, 01/3/14 - 12:50 pm
UCB
Amgen
bone density
romosozumab
Grading Pharma In 2013: 16 Drug Companies Ranked
Forbes
Tue, 12/31/13 - 10:17 am
Bristol-Myers Squibb
Celgene
Gilead Sciences
Biogen Idec
AbbVie
Roche
JNJ
GSK
Amgen
Novo Nordisk
Pfizer
Novartis
Merck
Sanofi
AstraZeneca
Eli Lilly
Acceleron, Celgene Vs. Amgen In The Anemia Drug Race
Seeking Alpha
Mon, 12/30/13 - 11:15 am
Amgen
Acceleron
Celgene
anemia
sotatercept
ACE-536
Biogen's Biosimilars Vs. Amgen, Johnson & Johnson
Seeking Alpha
Mon, 12/23/13 - 10:01 am
Amgen
Biogen Idec
biosimilars
JNJ
Samsung Bioepis
Celltrion
Hospira
Remsima
Inflectra
Biotech Stocks: A Year in Review
Yahoo/TheStreet.com
Fri, 12/20/13 - 08:34 am
Amgen
Teva
Forest Labs
AstraZeneca
Medivation
JNJ
Amgen cholesterol drug succeeds in late-stage trial
Yahoo/Reuters
Thu, 12/19/13 - 11:13 am
Amgen
cholesterol
evolocumab
PCSK9 inhibitors

Pages